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Neonatal seizures are commonly caused by hypoxic and/or ischemic injury during
birth and can lead to long-term epilepsy and cognitive deficits. In a rodent hypoxic
seizure (HS) model, we have previously demonstrated a critical role for seizure-induced
enhancement of the AMPA subtype of glutamate receptor (GluA) in epileptogenesis and
cognitive consequences, in part due to GluA maturational upregulation of expression.
Similarly, as the expression and function of the N-Methyl-D-aspartate (NMDA) subtype
of glutamate receptor (GluN) is also developmentally controlled, we examined how early
life seizures during the critical period of synaptogenesis could modify GluN development
and function. In a postnatal day (P)10 rat model of neonatal seizures, we found that
seizures could alter GluN2/3 subunit composition of GluNs and physiological function
of synaptic GluNs. In hippocampal slices removed from rats within 48–96 h following
seizures, the amplitudes of synaptic GluN-mediated evoked excitatory postsynaptic
currents (eEPSCs) were elevated in CA1 pyramidal neurons. Moreover, GluN eEPSCs
showed a decreased sensitivity to GluN2B selective antagonists and decreased Mg2+
sensitivity at negative holding potentials, indicating a higher proportion of GluN2A and
GluN3A subunit function, respectively. These physiological findings were accompanied
by a concurrent increase in GluN2A phosphorylation and GluN3A protein. These results
suggest that altered GluN function and expression could potentially contribute to future
epileptogenesis following neonatal seizures, and may represent potential therapeutic
targets for the blockade of future epileptogenesis in the developing brain.
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Introduction
Hypoxic encephalopathy is the most common cause of neonatal seizures, and can lead to
the development of long-term epilepsy and cognitive impairments (Jensen et al., 1992;
Jensen and Baram, 2000; Rakhade and Jensen, 2009; Bernard and Benke, 2015). Using a
rodent hypoxic seizure (HS) model, we have demonstrated that hypoxia at postnatal day
10 (P10) rats causes seizures with later consequences in adulthood, including increased
hippocampal (most sensitive to hypoxia; Jensen et al., 1992; Jensen and Baram, 2000)
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and cortical excitability, epilepsy, and neurobehavioral and
cognitive deficits (Rakhade and Jensen, 2009; Zhou et al., 2011;
Talos et al., 2012b; Lippman-Bell et al., 2013).
Numerous experimental models reveal that the developing
brain is more seizure-prone than the adult (Hellier and Dudek,
2005; Jacobs et al., 2009; Rakhade and Jensen, 2009; Dudek
and Staley, 2012). During the critical period of synaptogenesis
and plasticity in early brain development, excitatory ionotropic
glutamate receptors are overexpressed with unique subunit
compositions compared to adulthood (Rakhade and Jensen,
2009). In rodents, sensitivity to HS is highest during the second
postnatal week (Jensen et al., 1991; Jensen, 1995), which is the
critical period of brain development and synaptogenesis, and
hence evaluation of subunit expression may reveal age-specific
therapeutic targets for seizure control (Rakhade and Jensen,
2009).
The N-Methyl-D-aspartate (NMDA) subtype of glutamate
receptors (GluNs) are heteromeric and composed of different
subunits GluN1, GluN2 A-D and GluN3A-B that determine
excitatory postsynaptic currents (EPSC) amplitudes and
kinetics (Arrigoni and Greene, 2004; Karavanova et al., 2007;
Logan et al., 2007; Tong et al., 2008). The GluN2A:2B ratio
regulates decay kinetics of GluN EPSCs and efficacy of
synaptic plasticity, such as long term potentiation (LTP)
and long term depression (LTD). The GluN3A subunits
can decrease the Mg2+ blockade (Zhou et al., 2009) and
Ca2+ permeability, and enhance neuronal excitability
at resting potentials (Tong et al., 2008; Henson et al.,
2010).
Like the other glutamate receptor subtypes, the expression
and function of GluN (Jensen et al., 1992; Rakhade and Jensen,
2009; Bernard and Benke, 2015) subunits are developmentally
regulated and critical for neuronal migration and synapse
formation (Cull-Candy et al., 2001; Zhou et al., 2009;
Ohno et al., 2010). In the postnatal developing cortex and
hippocampus, synapses express GluNs first without GluAs,
which are named as silent synapses and contain GluN1s (Isaac
et al., 1997; Zhou et al., 2011). In the rodent cerebrum,
overall GluN expression transiently peaks at around P10
(Rakhade and Jensen, 2009; Manning et al., 2011; Talos
et al., 2012a; Jantzie et al., 2015). Importantly, there is a
developmental switch of GluN2 subunit composition from
GluN2B to GluN2A after the second postnatal week in rodent
cortex and hippocampus (Kirson and Yaari, 1996; Kumar and
Huguenard, 2003; Henson et al., 2008), with similar changes
being observed after infancy in humans (Law et al., 2003;
Jantzie et al., 2015). Higher GluN2B levels are associated with
longer open times and enhanced excitability of the immature
brain. In the adult brain, GluN2B appears to be upregulated
in epilepsy, as evidenced both from human biopsy tissue
with refractory epilepsy or rat epilepsy models (Law et al.,
2003; Bustos et al., 2014). Like the GluN2 subunits, the
GluN3A subunit is also highly developmentally regulated and
transiently overexpressed on hippocampal neurons during the
second postnatal week (Wong et al., 2002), and its presence
decreases Mg2+ blockade (Zhou et al., 2009) and enhances
neuronal excitability (Tong et al., 2008). Moreover, interference
of GluN3A expression during development can disrupt LTP
expression during development (Roberts et al., 2009; Henson
et al., 2010).
GluN subunits can be modulated by neuronal activity
especially during development (Kerchner and Nicoll, 2008)
and GluN2 subunits are phosphorylated by activity-dependent
protein kinases (at different serine/tyrosine sites), including the
PKA (serines in GluN1, GluN2A and GluN2C), PKC (serines
GluN1, GluN2A, GluN2B and GluN2C), CaMKII (serine in
GluN2B), Casein Kinase 2 (serine in GluN2B) and Src kinases
(at tyrosines in GluN2A, 2B and 2C; Chen and Roche, 2007;
Zhou et al., 2007; Zhang et al., 2008; Sanz-Clemente et al., 2010,
2013). This can lead to GluN2 subunit forward trafficking (such
as GluN2A at Y1387; Deak et al., 2009; Salter and Kalia, 2004) or
endocytosis (such as GluN2B at Y1472; Snyder et al., 2005) and
enhance/influence GluN functions (Zahavi et al., 1996; Zheng
et al., 1998).
Under conditions of hypoxia and/or ischemia and status
epilepticus in the immature brain, GluNs are excessively
activated and contribute to seizures and epileptogenesis (Sanchez
et al., 2000; Chen and Wasterlain, 2006). In the adult brain,
enhanced Ca2+ entry through GluNs during seizures can result
in altered signal transduction or excitotoxic death (Choi, 1995;
Wroge et al., 2012; Clasadonte et al., 2013), which is in part due to
altered expression of GluN2A/2B (Gashi et al., 2007; Kristiansen
et al., 2010). In this study, we hypothesized that early life
seizures could alter synaptic GluN-mediated eEPSC properties
and subunit-specific pharmacology, as well as different subunit
expression in the developing CA1 pyramidal neurons from P10
to P17. We found that HS increased GluN-eEPSC amplitudes in
CA1 pyramidal neurons at 48–96 h following HS at P10, which
was mediated by an increased GluN2A phosphorylation and
a slightly increased GluN3A subunit expression and function.
In addition, enhanced GluN eEPSCs following HS were less
sensitive to Mg2+ blockade, allowing GluN receptor activation
at resting membrane potentials. These alterations in GluN
receptors may contribute to later in life spontaneous seizures and
epileptogenesis following early life HS.
Materials and Methods
Animals
Male Long-Evans hooded rats (Charles River Laboratories,
Wilmington, MA, USA) were used in the study. HS at P10 were
induced as previously (Rakhade et al., 2008; Zhou et al., 2011).
Briefly, HS were induced in P10 rat pups by lowering the oxygen
concentration for 15 min (7% for 8 min, 5% for 6 min, and
4% for 1 min). Behavioral seizures, such as head bobbing, wet
dog shakes, and tonic-clonic movements, were scored for each
animal during 15 min hypoxia. Only rats showing more than five
behavioral seizures were included for further analysis. Littermate
control pups went through the same procedure with room air.
Body temperature was monitored and kept between 32–34◦C.
All pups were returned to their dams within an hour after the
experiment. All procedures were approved by and in accordance
with the guidelines of the Animal Care and Use Committee at
Boston Children’s Hospital (Boston, MA, USA). All efforts were
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made to minimize animal suffering and the number of animals
used.
Hippocampal Slice Preparation
Hippocampal slices were prepared as previously described (Zhou
et al., 2011). Rat pups were decapitated at 1, 24, 48, 96 h
and 1 week post-HS. Littermate rats without hypoxic exposure
at same ages were used as normoxic controls. Brains were
rapidly dissected from the skull and placed for sectioning in
ice-cooled cutting solution containing (mM): 210 Sucrose, 2.5
KCl, 1.02 NaH2PO4, 0.5 CaCl2, 10 MgSO4, 26.19 NaHCO3,
and 10 D-glucose, pH 7.4 bubbled with 95%O2/5%CO2 at 4◦C.
Coronal hippocampal slices (300 µm thickness) were sectioned
from the middle third of hippocampus with a vibratome (Leica
VT1000S, Heidelbeger, Germany) in cutting solution. Slices were
incubated in oxygenated artificial cerebrospinal fluid (ACSF)
with composition as previously described (Zhou et al., 2011;
Sun et al., 2013) and remained at 35◦C for 30 min. Then
slices were kept at room temperature for at least 1 h before
electrophysiological recordings.
Electrophysiology
Whole-cell patch clamp recordings were made from
hippocampal CA1 pyramidal neurons in brain slices using
IR-DIC microscope as previously described (Zhou et al.,
2009). The patch-pipette internal solution contained (in mM):
110 Cs-methanesulfonate, 10 TEA-Cl, 4 NaCl, 2 MgCl2, 10
EGTA, 10 HEPES, 4 ATP-Mg, and 0.3 GTP, pH 7.25, QX-314
(5 mM), phosphocreatine (7 mM) and creatine-phosphokinase
(17 unit/ml). Filled electrodes had resistances of 4–6 MΩ.
AMPA/KA receptors and γ-aminobutyric acid (GABA)
receptors were blocked with NBQX (20 µM) and picrotoxin
(60 µM) for all recordings unless otherwise specified. Evoked (e)
NMDA-mediated EPSCs were recorded at a holding potential of
+40 mV, except that for generating I-V curves for GluN-eEPSCs,
cells were held from−80mV to+50mV. The Schaffer collaterals
from CA3 to CA1 were stimulated at 30 s intervals to obtain
stimulus response curve (0.3 ms in duration). The intensity to
evoke 60–70% maximal response was used unless otherwise
specified. All recordings were performed at room temperature
(22–24◦C).
Data were collected using an Axopatch200B amplifier
(Molecular Devices Inc., Union City, CA, USA) and Clampex 9.2
software (Molecular Devices Inc., Union City, CA, USA) with
compensation for series resistance (70%) and cell capacitance,
filtered at 2 kHz, and digitized at 20 kHz using a Digidata
1320A analog to digital converter (Molecular Devices Inc., Union
City, CA, USA).
Western Blots
HS and littermate control rat pups were euthanized at
48–96 h after seizures (n = 10–20/group) and western
blot analysis of micro-dissected CA1 was performed with
modification of our previously published protocol (Talos
et al., 2012b). Briefly, hippocampal tissue was removed,
stretched along the septotemporal axis, and cut into 1 mm
sections along the perpendicular axis using a tissue slicer.
Sections were placed in chilled ACSF and the CA1 region
was isolated under a dissecting microscope. CA1 tissue was
pooled between two animals within each group, flash frozen
and processed for membrane protein preparations. Tissue
was homogenized in lysis buffer containing a Complete
Mini Protease Inhibitor Cocktail Tablet (Roche, Germany)
and the phosphatase inhibitors phenylmethanesulfonyl fluoride
(1 mM), sodium-orthovanadate (1 mM) and okadaic acid
(0.1 mM) to block protease and phosphatase activity. Equal
amounts of membrane proteins were electrophoresed on
4–20% Tris-HCl gels (Bio-Rad, Hercules, CA, USA) and
then transferred to polyvinylidenedifluoride membranes (Bio-
Rad). Immunoblots were incubated with GluN2A (1:500,
Millipore, Billerica, MA, USA), GluN2B (1:500, Millipore),
GluN2C (1:200,Millipore), GluN2D (1:500,Millipore), phospho-
GluN2A (Tyr1387; 1:350, abcam, Cambridge, MA, USA), or
phospho-GluN2B (Tyr1472; 1:500, abcam) primary antibodies
at 4◦C overnight. Membranes were then incubated with the
appropriate horseradish peroxidase-conjugated anti-rabbit or
anti-mouse IgG secondary antibodies (1:5000, Pierce, Rockford,
IL, USA). Protein bands were visualized with enhanced
chemiluminescence (Pierce), and measured with the Image
Reader LAS-4000 system and Image Gauge v3.0 software
(Fujifilm). To control for differences in protein loading, raw
values were normalized to corresponding β-actin (Sigma-
Aldrich) within each immunoblot. Normalized values for each
protein were expressed as a percent of the mean expression level
of littermate control tissues. Pups in the different groups for same
control or HS treatment were pooled to be averaged.
Statistics
Data was tested for normality using the Shapiro-Wilk normality
test. Statistical significance was assessed using a Student’s t test,
or a one-way ANOVA test when more than two groups were
compared for data with normal distributions, and a Mann-
Whitney or Wilcoxon matched-pairs signed rank test for
comparisons of data that were not normally distributed p < 0.05
was considered statistically significant. All results were expressed
as mean± standard error otherwise specified.
Results
HS Cause an Early Transient Increase in
GluN-Mediated Evoked EPSC Amplitude
We examined whether early life HS could alter GluN function as
the NMDA subtype of glutamate receptor expression undergoes
significant differential regulation during postnatal development
(Rakhade and Jensen, 2009). GluN receptors critically contribute
to neuronal excitability and seizures (Ghasemi and Schachter,
2011), and in turn they can be altered by neuronal activity
(Sanchez et al., 2000; Yashiro and Philpot, 2008; Clasadonte
et al., 2013). In this study, we measured evoked GluN-
mediated excitatory postsynaptic currents (GluN eEPSCs) from
hippocampal CA1pyramidal neurons from 1 h to 7 days post-
HS neonatal rats and their littermate controls. GluN eEPSCs
in hippocampal CA1 pyramidal neurons showed a peak in
amplitude around postnatal (P) 12–14 in both normoxic control
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FIGURE 1 | Hypoxic seizures (HSs) enhance GluN function in
hippocampal CA1 pyramidal neurons from P10 to P17.
(A) Representative traces of GluN-mediated eEPSCs, pharmacologically
isolated by blocking GluA and GABAA receptors, at a holding potential of +40
mV in hippocampal ex vivo slices from control and 96 h post-HS rats.
(B) GluN-mediated eEPSC amplitude is significantly larger in neurons from
48–96 h post-HS rats (p < 0.05, n = 11 cells), but not in neurons from 1–24 h
post-HS rats (p > 0.05, n = 11 cells) and 1 week post-HS rats (p > 0.05, n = 6
cells), compared to littermate control rats (n = 6–10 cells). ∗p < 0.05. Error
bars indicate S.E.M.
rats and post-HS rats (Figures 1A,B). In contrast, GluN eEPSCs
showed significantly higher amplitudes in CA1 pyramidal
neurons from 48–96 h post-HS rats compared to controls
(post-HS 48–96 h: 52.51 ± 6.28pA, n = 11 cells vs P12–14
normoxic controls: 29.98 ± 3.84pA, n = 10 cells, p = 0.002,
Figures 1A,B), while no significant changes were found at earlier
(1–24 h) or later (7 days) time points post HS (n = 10–11 cells,
p > 0.05). These results demonstrate a transient enhancement in
GluN eEPSC amplitude following HS in the developing brain,
suggesting that function of GluNs during postnatal 48–96 h is
sensitive to early hypoxia-induced seizures.
HS Induced Alterations in GluN2 Function and
Expression
Given that HS-induced changes in GluN eEPSC amplitudes,
we next determined whether this was mediated by post-HS
alteration in GluN subunits. GluN2A and GluN2B-containing
GluNs can be pharmacologically distinguished by sensitivity to
blockade by the GluN2B specific blocker ifenprodil (Arrigoni and
Greene, 2004). In CA1 pyramidal neurons from hippocampal
slices fromP12–14 control animals, bath application of ifenprodil
(5µM) significantly decreased GluN eEPSC amplitudes by about
50% (48.62 ± 7.67%, n = 11 cells, Figure 2). In contrast, the
FIGURE 2 | Hypoxic seizure-induced increases in GluN2A-containing
GluN eEPSCs. (A) Representative GluN eEPSC traces before (black) and
after bath application of 5 µM ifenprodil (gray) in hippocampus CA1
pyranmidal neurons at +40 mV holding potential from control and 96 h
post-HS rats. (B) Group data of ifenprodil sensitivity in CA1 pyramidal neurons
in slices from 1–24 h (n = 11 cells), 48–96 h (n = 11 cells) and 1 week post-HS
rats (n = 5 cells) and slices from littermate controls (n = 6–10 cells). ∗p < 0.05.
Error bars indicate S.E.M. (C) Group data of absolute GluN2A-containing
GluN eEPSC amplitude (ifenprodil insensitive component) in CA1 pyramidal
neurons in slices from 1–24 h (n = 11 cells), 48–96 h (n = 11 cells) and 1 week
post-HS rats (n = 5 cells) and slices from littermate controls (n = 6–10 cells).
∗p < 0.05. Error bars indicate S.E.M. (D) Group data of absolute
GluN2B-containing GluN eEPSC amplitude (ifenprodil sensitive component) in
CA1 pyramidal neurons in slices from 1–24 h (n = 11 cells), 48–96 h (n = 11
cells) and 1 week post-HS rats (n = 5 cells) and slices from littermate controls
(n = 6–10 cells). Error bars indicate S.E.M.
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ifenprodil sensitivity was significantly lower in CA1 pyramidal
neurons in slices from post-HS 48–96 h rats (19.74 ± 4.51%
reduction, n = 10 cells, p = 0.009, Figure 2). Moreover, HS
subacutely increased the absolute eEPSC amplitude mediated
by ifenprodil-insensitive GluN2A-containing GluNs at 48–96 h
post-HS (P12–14 control: 15.19 ± 3.18pA; post-HS 48–96 h:
39.37 ± 4.50pA, n = 10–11 cells, p = 0.0004, Figure 2C). In
contrast, at this same time point, there were no changes in
the amplitude of ifenprodil-sensitive GluN2B-containing GluNs
at 48–96 h post-HS (P12–14 control: 12.75 ± 3.20pA; post-
HS 48–96 h: 9.66 ± 3.00pA, n = 10–11 cells, p = 0.49,
Figure 2D). These data suggest that the absolute increases in
GluN2A-containing GluN function, without a change in GluN2B
function, underlies the sub-acute post-HS enhancement in GluN
function. To confirm our findings with ifenprodil, we also
tested eEPSC subunit pharmacology with Ro-25–6981, another
selective antagonist blocking GluN2B-containing GluNs (Kark
et al., 1995; Oren et al., 1995), and similar findings were seen
(at P11 normoxia, eEPSC blockade percentage 44.64 ± 7.05%,
n = 5 by ifenprodil (5 µM) vs 36.6± 6.34%, n = 3 by Ro-25–6981
(0.8µM); at P11HS, eEPSC blockade percentage 20.23± 10.99%,
n = 6 by ifenprodil vs 18.5± 4.36%, n = 3 by Ro-25-6981).
To further confirm the post-HS changes in NMDA
receptor GluN2A/B subunit composition, we analyzed the
membrane protein expression levels of GluN2A and 2B in
the microdissected hippocampal CA1 region from 48–96 h
post-HS rats and their littermate controls. We found that
GluN2A subunit expression in 1 through to 96 h post-HS rats
did not show significant changes compared to their littermate
controls (P10–11 controls: 100 ± 16.96%; 1–24 h post-HS rats:
155.22 ± 27.21%, n = 20, p = 0.09 and P12–14 controls: 100 ±
12.08%; 48–96 h post-HS rats: 135.66± 21.06%, n = 20, p = 0.15,
Figure 3A). However, GluN2A phosphorylation at Y1387 in CA1
region at 48–72 h post-HS was significantly increased compared
to P12–14 control levels (P12–14 controls: 100 ± 11.31%;
48–96 h post-HS rats: 170.28 ± 12.21%, n = 20, p = 0.001,
Figure 3B), not at 1–24 h (P10–11 controls: 100 ± 14.38%;
1–24 h post-HS rats: 137.98± 12.13%, n = 20, p = 0.07). GluN2A
tyrosine (Y1387) phosphorylation functions to incorporate
GluN2A subunits into GluNs and enhances GluN function
(Chen and Roche, 2007; Zhou et al., 2007; Zhang et al., 2008;
Sanz-Clemente et al., 2010, 2013). Our results suggest an increase
in GluN2A function at 48–96 h following HS.
In contrast, GluN2B subunit expression in CA1 from 48–96 h
post-HS rats did not show significant changes compared to that
of their littermate controls from P10 through to P14 (P10–11
controls: 100 ± 10.93%; 1–24 h post-HS rats: 75.09 ± 10.07%,
n = 20, p = 0.10 and P12–14 controls: 100 ± 9.72%; 48–96 h
post-HS rats: 86.10 ± 9.89%, n = 20, p = 0.32, Figure 3C).
In addition, phosphorylation of the GluN2B (Y1472) subunit
influences the stability of GluN2B in the cell surface membrane
(Sanz-Clemente et al., 2010, 2013), and HS did not alter levels
of phosphorylation at the Y1472 subunit of GluN2B from P10
through to P14 (P10–11 controls: 100± 12.03%; 1–24 h post-HS
rats: 97.01± 16.44%, n = 10, p = 0.88 and P12–14 controls: 100±
13.22%; 48–96 h post-HS rats: 106.05± 15.91%, n = 10, p = 0.77,
Figures 3D–F).
Despite the subacute changes in GluN2 subunits expression,
there were no changes in GluN1 subunit expression following
HS from P10 through to P14 (at P10–P11 control 100 ± 10.36%,
n = 10 vs 1–24 h post-HS rats: 101.74 ± 13.12%, n = 10,
t-test p = 0.918; at P12–14 control 117.03 ± 15.60%, n = 10 vs
48–96 h post-HS rats: 126.46 ± 17.46%, n = 10, t-test p = 0.691).
Taken together, these data indicate that HS in the immature brain
induce a specific subacute increase in GluN2A phosphorylation
and function.
HS Decreased Mg2+-Sensitivity
of GluN-Mediated eEPSCs
Mg2+ sensitivity is one of the critical factors affecting GluN
function, and determined by GluN subunit composition
(Zhou et al., 2009) as well as post-translational modification
FIGURE 3 | Hypoxic seizures-induced increases in GluN2A subunit phosphorylation at 48–96 h post-HS. (A–C) Western blot quantification of total and
Phospho-GluN2A subunit (Y1387) in micro-disected hippocampus CA1 from control and 48–96 h post-HS rats (n = 20, 20). ∗p < 0.05. Error bars indicate S.E.M.
(D–F) Western blot quantification of total and Phospho-GluN2B subunit (Y1472) in micro-dissected hippocampus CA1 from control and 48–96 h post-HS rats
(n = 10, 10). Error bars indicate S.E.M.
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FIGURE 4 | Reduction of Mg2+-sensitivity of GluN eEPSCs at 48–96 h in
hippocampal CA1 neurons following HS. (A,B) Representative traces of
evoked GluN EPSCs (left panels) at a holding potential from −80 mV to
+50 mV in ACSF with/without Mg2+ (1.2 mM) in CA1 pyramidal neurons in
slices from control and 96 h post-HS rats. Right panels, corresponding I-V
plots of the peak amplitudes of GluN eEPSCs. (C) GluN eEPSC I-V curves
(with 1.2 mM Mg2+ in ACSF) and corresponding fitted Woodhull curves in
CA1 pyramidal neurons in slices from control (empty circles) and 96 h post-HS
rats (filled circles). (D) Group data of fitted Woodhull Kd values in CA1
pyramidal neurons in slices from 1–24 h (n = 10 cells), 48–96 h (n = 12 cells), 1
week post-HS (n = 5 cells) and littermate control rats (n = 5–11 cells). ∗p <
0.05. Error bars indicate S.E.M.
(Chen and Huang, 1992). GluN3A subunit confers decreased
Mg2+ sensitivity and is developmentally upregulated in the
first 2 postnatal weeks (Zhou et al., 2009). We thus examined
the Mg2+-sensitivity of GluN eEPSCs in CA1 pyramidal
neurons within postnatal period P12–14 by evoking EPSCs at
holding potentials from −80 through +50 mV and measuring
linear I-V curves in Mg2+-free ACSF. With 1.2 mM Mg2+
added into ACSF, inward currents at holding potentials
from −80 to 0 mV were suppressed and maximal inward
currents appeared at around −30 or −20 mV, exhibiting
a typical J-shape I-V curve (Figure 4A). In contrast to
age-matched controls (−16.53 ± 4.12 pA, n = 7 cells),
maximal inward currents at a holding potential of −30 mV
in 48–96 h post-HS rats (−36.85 ± 7.31pA, n = 7 cells)
were significantly larger (Figure 4), suggesting that Mg2+
sensitivity of GluNs in post-HS rats is decreased (t-test,
p = 0.032).
To quantify the GluN eEPSC Mg2+sensitivity, we applied the
Woodhull equation to fit eEPSC I-V curves to derive the Mg2+
sensitivity constant Kd (Zhou et al., 2009). Following HS, GluN
eEPSCs showed a significantly decreased Mg2+ sensitivity in
CA1 pyramidal neurons from 48–96 h post-HS rats compared to
their littermate controls (48–96 h post-HS Kd: 10.96 ± 1.96mM
(smaller sensitivity), n = 12 cells; P12–14 control Kd: 5.52 ±
0.92 mM (higher sensitivity), n = 11 cells, p = 0.024, Figure 4).
These results indicate that the Mg2+ sensitivity of GluN eEPSCs
in post-HS rats was reduced compared to age-matched controls,
which would further increase GluN function and contribute to
the enhancement of neuronal excitability.
Given decrease in Mg2+ sensitivity, we evaluated whether
GluN3A protein expression in the CA1 region of P12–14
rats was altered after seizures at P10 (Figure 5). While there
were no significant changes in total protein levels, we found
a trend toward increased levels of GluN3A expression in
48–96 h post-HS group compared to their littermate controls
(P12–14 controls: 100 ± 8.45%; 48–96 h post-HS rats: 127.41 ±
11.85%, n = 10, p = 0.075, Figure 5). At earlier time points
there was no significant changes at 1–24 h post-HS (P10–11
controls: 100 ± 15.92%; 1–24 h post-HS rats: 118.11 ± 14.90%,
n = 10, p = 0.41).
Because GluN2C/2D containing GluNs can also regulate
Mg2+ sensitivity, we tested for changes in their expression in
the same time window. GluN2C/D subunits were functionally
present during these periods (P10–17), indicated by NMDA
eEPSC blockade of 60% with 0.8 µM cis-PPDA (antagonist
for GluN2C/D containing GluNs) and could influence GluN
Mg2+ sensitivity. However, we did not find any significant
difference in GluN2C/D function as indicated by eEPSC
blockade with cis-PPDA between control and post-HS rats
(P10–11 control: 59.47 ± 7.63%, n = 3 cells, 1–24 h post-
HS: 57.32 ± 11.85% n = 4 cells; P12–14 control: 50.03 ±
5.69%, n = 8 cells, 48–96 h post-HS: 55.73 ± 4.53%, n = 13
cells; P17 control: 59.47 ± 7.63%, n = 4 cells, P17 post-
HS: 58.65 ± 8.36%, n = 5 cells; all p > 0.05). These data
indicate that HS-induced changes in GluN3A expression and
functionmaymediate the reduction ofMg2+ sensitivity of GluNs
following HS.
FIGURE 5 | Hypoxic seizures slightly increase GluN3A subunit
expression in hippocampal CA1 neurons. (A) Representative Western blot
of GluN3A subunit in micro-dissected hippocampus CA1 from control and
96 h post-HS rats. (B) Western blot quantification of total GluN3A subunit
expression in micro-dissected hippocampus CA1 from control and 48–96 h
post-HS rats (n = 10, 10, p = 0.075). Error bars indicate S.E.M.
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Discussion
In the present study, we investigated how early life seizures
affected NMDA subtype of glutamate receptor (GluN) subunit
composition and function in addition to previously identified
enhancement in GluA function (Rakhade et al., 2008; Zhou
et al., 2011; Sun et al., 2013) in an established neonatal HS
model. While increasing evidence supports that GluNs may be
critically involved in epileptogenesis in human epilepsy (Endele
et al., 2010) and adult animal models of epilepsy (see review
in Ghasemi and Schachter, 2011), the role of GluNs in early
life epilepsy is still not fully understood (Nairismagi et al.,
2006; Swann et al., 2007a). Here, we show that HS enhanced
synaptic GluN subunit function and expression in hippocampal
CA1 pyramidal neurons. Early post-seizure enhancement of
GluN function was in part mediated by increases in GluN2A
phosphorylation and GluN3 subunit expression. This overall
enhancement of GluN may contribute to enhanced neuronal
excitability and epileptogenesis, as well as an alteration of
synaptic plasticity seen in this model. These data raise the
possibility that modulation of specific GluN subunits may have
therapeutic value in preventing cognitive deficits related to
seizure-induced alterations in synaptic function.
Mechanisms Underlying Enhanced GluN eEPSCs
and Elevated Neuronal Excitability Following HS
We demonstrated that early-life HS induced an increase in
GluN2A and GluN3A function and expression at 48–96 h post-
HS in hippocampal CA1 pyramidal neurons. The compositional
diversity of GluN2 subunits critically determines the functions
of GluNs (Cull-Candy et al., 2001; Chen and Roche, 2007)
as well as their roles in the pathophysiology of epilepsy
(Ying et al., 2004; Di Maio et al., 2013). GluN2B-containing
GluNs have longer channel activating duration and slow
deactivation compared to GluNs containing GluN2A subunits
(Hilzenrat et al., 1996). Dynamic changes in GluN2A and
GluN2B subunits during development result in different
combinations of hippocampal NR1/GluN2A, NR1/GluN2B, and
NR1/GluN2A/GluN2B receptors (Luo et al., 1997; Hawkins
et al., 1999). Normally during development there is a relative
abundance of GluN2B subunits, and GluN2A subunits gradually
increase during development and are more prevalent in
adulthood (Tang et al., 2001; Clayton et al., 2002; Cui
et al., 2013). In our model of epilepsy in the immature
brain, we found a decreased proportion of GluN2B-containing
NMDA eEPSCs in post-HS rats. This was not due to
an absolute decrease in GluN2B-containing GluNs, but an
increase in the absolute amount of GluN2A-containing receptors
likely mediated by the observed increase in GluN2A subunit
phosphorylation (Y1387 by Src kinase). The Y1387 site on
GluN2A is phosphorylated in an activity dependent manner
by Src kinase (Ali and Salter, 2001; Salter and Kalia,
2004) and contributed to synaptic plasticity, yet this is the
first documentation of this posttranslational change being
mediated by seizures. We also observed a strong trend of
increase in GluN3A subunits, which could result in less
Mg2+ blockade of GluNs at negative holding potentials,
increasing the likelihood of activation. The decreased Mg2+
blockade was likely specific to increases in GluN3A, as we
did not observe significant changes of GluN2C/D containing
GluN eEPSCs which are also known to regulate Mg2+
sensitivity of GluNs. Taken together, the enhanced GluN
function following HS in the immature brain appears to
be primarily due to an upregulation of both GluN2A (Src
phosphorylation) and GluN3A-containing GluNs. This pattern
is distinct from that in the adult brain, where increases of
GluN2B-containing GluNs have been reported in adult epileptic
tissue and adult rodent models (DeFazio and Hablitz, 2000;
Ying et al., 2004; Borbély et al., 2009; Durakoglugil et al.,
2009; Sun et al., 2009; Endele et al., 2010; Di Maio et al.,
2013).
GluN2A and GluN2B subunit function can be modulated by
post-translational phosphorylation.We have previously reported
an increase in the activity of several kinases, including PKA,
PKC, CamKII and TrkB, during the subacute period following
HS (Rakhade et al., 2008; Obeid et al., 2014). Phosphorylation
of GluNs can also influence the amplitude of GluNs and
Mg2+ sensitivity (Chen and Huang, 1992). Phosphorylation of
GluN2A and GluN2B can influence their membrane surface
expression or endocytosis (Chen and Roche, 2007), which can
directly contribute to GluN current amplitudes and change
neuronal excitability. Such post-translational modification has
been reported to occur in models of synaptic plasticity, but this
is the first report of such a change in the epileptic immature
brain.
There were no alterations in GluN1 total subunit protein
following HS in the current study. However, this result is
consistent with our previous immunocyto-chemical finding in
silent synapse study (Zhou et al., 2011), in which synaptic GluN1
labeling is not altered at post-HS 48 h, although the colocalization
with GluA1 is increased. The present study builds upon the
fact that in addition to an unsilencing of GluN receptors by
seizures, the kinetics of the NMDA receptor is further modified
by GluN2A and GluN3A alterations.
Enhanced GluN2A Function by Phosphorylation
would Facilitate its Role of Pro-Epileptogenesis
Following HS
The GluN2A subunit has been previously shown to increase due
to epileptic activity in animal seizure models (Hellier et al., 2009;
Gibbs et al., 2011; Reid et al., 2012; see Chen et al., 2007 for
a reduction of GluN2A following flurothyl-induced recurrent
neonatal seizures), whichmay also be associated with mossy fiber
sprouting (Swann et al., 2007b). In the present study, we found
that the increase in GluN2A subunit phosphorylation accounts
for HS-induced reduction of ifenprodil sensitivity, rather than
a change in the absolute levels of GluN2B. GluN2A subunit
phosphorylation at Y1387 is mediated by Src kinase, which
can decrease tonic zinc inhibition of GluNs at synapses (Eaton
et al., 1995; Perouansky et al., 1996; Zahavi et al., 1996). This
may account for enhancement of GluN2A containing GluN
eEPSCs without an observed increase of GluN2A expression.
Hamada et al. (2014) clearly showed that one main function
of NR2A subunit is to regulate AMPARs into synaptic sites
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during neonatal period. Gray et al. (2011) showed that deletion
of GluN2A subunit will decrease synaptic strength. These would
imply that increase of GluN2A function due to phosphorylation
in our current study would lead to higher neuronal excitability
through enhanced GluA function, consistent with our previous
findings (Rakhade et al., 2008; Zhou et al., 2011).
GluN3A may Contribute to the Post-HS Neuronal
Excitability
GluN3A containing GluNs exert critical effects on GluN receptor
function and neuronal excitability in the immature brain
(Henson et al., 2010). We showed that early life seizures
decreased GluN Mg2+ sensitivity, suggestive of a increase
in GluN3A protein expression in CA1 neurons at 48–96 h
post-HS, although we only were able to show a trend in
protein expression (due to commercial antibody unavailability
of potential GluN3A phosphorylation (Henson et al., 2010),
we can not exclude that the possible elevated/altered GluN3A
phosphorylation may enhance GluN3A functions following HS).
The GluN3A subunit is most highly expressed during the
early developmental period (Zhou et al., 2009; Henson et al.,
2010; Sucher et al., 2010). One of most prominent features
of GluN3A-containing GluNs is almost complete insensitivity
to Mg2+ blockade at a hyperpolarized potential (Sasaki et al.,
2002; Henson et al., 2010). Incorporation of more GluN3A
subunits into GluNs has been shown to increase the currents
at resting potentials (Zhou et al., 2009), which would result
in elevated neuronal excitability (Espinosa and Kavalali, 2009)
and seizures which is implied in human epileptic patients with
mutant GluNs with decreased Mg2+ blockade and less Ca2+
permeability (Endele et al., 2010). In our study, the increase
of eEPSC amplitudes at negative potentials is likely due to
HS-induced decreases in Mg2+ blockade of GluNs at negative
potentials (Zhou et al., 2009), which allows GluNs to be active
at negative membrane potentials and makes CA1 pyramidal
neurons more excitable at resting membrane potential. While
GluN2C/2D subunits can also regulate Mg2+ sensitivity, we were
able to rule out a contribution due to these subunits as there
was no differential sensitivity to the GluN2C/D blocker cis-
PPDA on GluN-eEPSCs between normoxic control and post-
HS group. Thus, in our study, HS-induced a strong trend
of increases in the expression of GluN3A subunit may be
more likely to cause of the decreased Mg2+ sensitivity of
GluNs. While the GluN3A total protein expression is not
significantly altered, the fact that our results show that GluN2C
or GluN2D are unaltered, it is possible that future studies can
examine post-translational modifications as antibodies become
available.
HS-Induced Alteration of Critical Elements
of GluNs that Regulate Synaptic Plasticity
Following HS
GluNs have been demonstrated to be involved in synaptic
plasticity in previous studies (Flint et al., 1997; Morishita
et al., 2007; Yashiro and Philpot, 2008; Cho et al., 2009).
The subunit composition of GluNs has been shown to be
involved in LTP or LTD induction. In our study, more GluN2A
containing GluNs seem to be expressed following HS compared
with GluN2B containing GluNs, which overlaps with the time
window (P12–14) when LTP expression is occluded (Zhou
et al., 2011). Specifically, more GluN2A (or less GluN2B)
containing GluNs decreases the amplitude of LTP (Massey
et al., 2004; Bartlett et al., 2007; Cho et al., 2009). The increase
of GluN2A containing GluNs could induce rapid kinetics of
GluNs, and therefore less Ca2+ influx, which may prevent
the trafficking GluAs to synapses and thus contribute to LTP
occlusion following neonatal seizures (Gambrill and Barria, 2011;
Zhou et al., 2011). In addition to GluN2A, incorporation of
GluN3A subunit into GluNs decreases GluNs’ Ca2+ permeability
and Mg2+ blockade, which could also result in the deficit of
synaptic plasticity (Roberts et al., 2009; Larsen et al., 2011).
Thus, increases of both GluN2A and GluN3A containing GluNs
following neonatal seizures could reduce neuronal capability to
induce LTP, which is consistent with our previous finding of
LTP occlusion at 48–72 h post neonatal seizures (Zhou et al.,
2011).
In summary, this study has provided the evidence that
GluNs are involved in early-life HSs and very likely contribute
to neuronal hyper-excitability and later life epileptogenesis.
This finding complements our previous findings on critical
roles of HS-induced enhancement on GluA expression and
function in early life epilepsy (Rakhade et al., 2008; Zhou et al.,
2011; Lippman-Bell et al., 2013), and provides an additional
mechanism whereby seizures in the immature brain can cause
a dysmature state. These data suggest that modulation of
specific GluN subunits may represent a new potential therapeutic
target in preventing cognitive deficits related to seizure-induced
alterations in synaptic function and impairment in synaptic
plasticity.
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